» Articles » PMID: 19188810

Prevalence, Awareness, Treatment and Control of High Blood Pressure in a Swiss City General Population: the CoLaus Study

Overview
Date 2009 Feb 4
PMID 19188810
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study is aimed to assess the prevalence of awareness, treatment and control of high blood pressure (HBP) and associated factors in a Swiss city.

Design: Population-based cross-sectional study of 6182 participants (52.5% women) aged 35-75 years living in Lausanne, Switzerland.

Methods: HBP was defined as blood pressure >/=140/90 mmHg or current antihypertensive medication.

Results: The overall prevalence of HBP was 36% (95% confidence interval: 35-38%). Among participants with HBP, 63% were aware of it. Among participants aware of HBP, 78% were treated, and among those treated, 48% were controlled (BP <140/90 mmHg). In multivariate analysis, HBP prevalence was associated with older age, male sex, low educational level, high alcohol intake, awareness of diabetes or dyslipidaemia, obesity and parental history of myocardial infarction. HBP awareness was associated with older age, female sex, awareness of diabetes or dyslipidaemia, obesity and parental history of myocardial infarction. HBP control was associated with younger age, higher educational level and no alcohol intake. Alone or in combination, sartans were the most often prescribed antihypertensive medication category (41%), followed by diuretics, beta-blockers, angiotensin converting enzyme inhibitors and calcium channel blockers. Only 31% of participants treated for HBP were taking >/=2 antihypertensive medications.

Conclusion: Although more than half of all participants with HBP were aware and more than three-quarters of them received a pharmacological treatment, less than half of those treated were adequately controlled.

Citing Articles

Twenty-year trends of potentially avoidable hospitalizations for hypertension in Switzerland.

Marques-Vidal P, Maung K, Gouveia A Hypertens Res. 2024; 47(10):2847-2854.

PMID: 39169149 PMC: 11456504. DOI: 10.1038/s41440-024-01853-x.


Physical Activity and Hypertension.

Hayes P, Ferrara A, Keating A, McKnight K, ORegan A Rev Cardiovasc Med. 2024; 23(9):302.

PMID: 39077709 PMC: 11262345. DOI: 10.31083/j.rcm2309302.


Developing and testing a framework for coding general practitioners' free-text diagnoses in electronic medical records - a reliability study for generating training data in natural language processing.

Wallnofer A, Burgstaller J, Weiss K, Rosemann T, Senn O, Markun S BMC Prim Care. 2024; 25(1):257.

PMID: 39014311 PMC: 11251376. DOI: 10.1186/s12875-024-02514-1.


Impact of the COVID-19 pandemic on CVD prevention between different socioeconomic groups in Switzerland.

Maung K, Marques-Vidal P Open Heart. 2023; 10(2).

PMID: 37730269 PMC: 10510922. DOI: 10.1136/openhrt-2023-002368.


No association between genetic markers and hypertension control in multiple cross-sectional studies.

Chekanova V, Vaucher J, Marques-Vidal P Sci Rep. 2023; 13(1):11811.

PMID: 37479854 PMC: 10362004. DOI: 10.1038/s41598-023-39103-8.